ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.01 and traded as high as $0.01. ProtoKinetix shares last traded at $0.01, with a volume of 360,000 shares traded.
ProtoKinetix Trading Down 16.8 %
The company has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.
Recommended Stories
- Five stocks we like better than ProtoKinetix
- Compound Interest and Why It Matters When Investing
- Oracle Announces Game-Changing News for the AI Industry
- Following Congress Stock Trades
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What Are Dividend Achievers? An Introduction
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240521153233&h=45&w=95&zc=2){kind=logo}